Evidence map›Paper›PMID 35745296›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Interaction Mechanisms and Application of Ozone Micro/Nanobubbles and Nanoparticles: A Review and Perspective.

Wei Xiao, He Zhang, Xiaohuan Wang, Biao Wang, Tao Long, Sha Deng, Wei Yang

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei XiaoSchool of Resources Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.ORCID 0000-0001-5245-4926
He ZhangSchool of Resources Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Xiaohuan WangSchool of Economics and Technology, Anhui Agricultural University, Hefei 230036, China.
Biao WangAnhui Hengyu Environmental Protection Equipment Manufacturing Company Limited, Fuyang 230036, China.
Tao LongSchool of Resources Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Sha DengSchool of Resources Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Wei YangSchool of Resources Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.

Funding

National Natural Science Foundation of China 5200040278Natural Science Basic Research Program of Shaanxi 2020JQ-667
6 · The paper itself

Abstract

Ozone micro/nanobubbles with catalytic processes are widely used in the treatment of refractory organic wastewater. Micro/nanobubble technology overcomes the limitations of ozone mass transfer and ozone utilization in the application of ozone oxidation, and effectively improves the oxidation efficiency of ozone. The presence of micro/nanobubbles keeps the catalyst particles in a dynamic discrete state, which effectively increases the contact frequency between the catalyst and refractory organic matter and greatly improves the mineralization efficiency of refractory organic matter. This paper expounds on the characteristics and advantages of micro/nanobubble technology and summarizes the synergistic mechanism of microbubble nanoparticles and the mechanism of catalyst ozone micro/nanobubble systems in the treatment of refractory organics. An interaction mechanism of nanoparticles and ozone microbubbles is suggested, and the proposed theories on ozone microbubble systems are discussed with suggestions for future studies on systems of nanoparticles and ozone microbubbles.

Indexed as

hydroxyl radicalozone micro/nanobubblesphenolic pollutantsphotocatalysistitanium dioxide

Identifiers

PMID35745296
PMCPMC9228162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.